Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 3/20 | 0.62 |
| ▸ | TFPI | P10646 | 4/20 | 0.60 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.60 |
| ▸ | NPY2R | P49146 | 6/20 | 0.60 |
| ▸ | NPY4R | P50391 | 6/20 | 0.60 |
| ▸ | NPY5R | Q15761 | 6/20 | 0.60 |
| ▸ | NPY1R | P25929 | 4/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23895426 | 0.95 | OPRD1 (0.60) | OPRD1TFPINTSR1NPY2RNPY4R | |
| SCHEMBL23895410 | 0.95 | OPRD1 (0.60) | OPRD1TFPINTSR1NPY2RNPY4R | |
| SCHEMBL30712913 | 0.90 | NPY2R (0.64) | OPRD1TFPINPY2RNPY4RNPY5R | |
| SCHEMBL31182450 | 0.88 | NPY2R (0.66) | TFPINPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL29581485 | 0.88 | NPY2R (0.64) | TFPINPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30607473 | 0.87 | NPY2R (0.63) | TFPINPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30906464 | 0.87 | NPY2R (0.70) | TFPINPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL11191224 | 0.87 | OPRD1 (0.75) | OPRD1NTSR1 | |
| Analog Of Dynorphin A SCHEMBL27861937 | 0.87 | OPRD1 (0.75) | OPRD1NTSR1 | |
| SCHEMBL31182841 | 0.87 | TFPI (0.66) | TFPINPY2RNPY4RNPY5RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210308211-A1 | METHOD OF TREATING VIRAL INFECTIONS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2021-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210308211-A1 | METHOD OF TREATING VIRAL INFECTIONS | IRF3, IRF2BP2, STAT4 | OPRD1 3957/4885TFPI 3195/4885NTSR1 2984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.